Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Nacev

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Plos One|October 5, 2011
Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazoleBenjamin A Nacev, Jun O Liu
Molecular Cell|March 31, 2009
It takes two binding sites for calcineurin and NFAT to tangoJun O Liu, Benjamin A Nacev, Jing Xu, et al.
ACS Medicinal Chemistry Letters|September 28, 2011
Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of ItraconazoleWei Shi, Benjamin A Nacev, Shridhar Bhat, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survivalKathryn Demanelis, Julia Leix, Melissa A Burgess, et al.
Plos One|March 17, 2015
Cyclosporin a disrupts notch signaling and vascular lumen maintenanceRaghav Pandey, Mark A Botros, Benjamin A Nacev, et al.
Biochemistry|June 5, 2010
Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidasesQing Xiao, Feiran Zhang, Benjamin A Nacev, et al.
Virchows Archiv : an International Journal of Pathology|July 30, 2024
Novel dual gene fusions identified in a late pulmonary metastasis of an infantile fibrosarcoma-like tumorKaren Schoedel, Shaymaa Hegazy, Megan L Zilla, et al.
The Journal of Biological Chemistry|October 26, 2011
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cellsBenjamin A Nacev, Paola Grassi, Anne Dell, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
ATRX guards against aberrant differentiation in mesenchymal progenitor cellsYan Fang, Douglas Barrows, Yakshi Dabas, et al.
Journal of Medicinal Chemistry|September 23, 2011
Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signalingWei Shi, Benjamin A Nacev, Blake T Aftab, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Plos One|October 5, 2011
Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazoleBenjamin A Nacev, Jun O Liu
Molecular Cell|March 31, 2009
It takes two binding sites for calcineurin and NFAT to tangoJun O Liu, Benjamin A Nacev, Jing Xu, et al.
ACS Medicinal Chemistry Letters|September 28, 2011
Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of ItraconazoleWei Shi, Benjamin A Nacev, Shridhar Bhat, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survivalKathryn Demanelis, Julia Leix, Melissa A Burgess, et al.
Plos One|March 17, 2015
Cyclosporin a disrupts notch signaling and vascular lumen maintenanceRaghav Pandey, Mark A Botros, Benjamin A Nacev, et al.
Biochemistry|June 5, 2010
Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidasesQing Xiao, Feiran Zhang, Benjamin A Nacev, et al.
Virchows Archiv : an International Journal of Pathology|July 30, 2024
Novel dual gene fusions identified in a late pulmonary metastasis of an infantile fibrosarcoma-like tumorKaren Schoedel, Shaymaa Hegazy, Megan L Zilla, et al.
The Journal of Biological Chemistry|October 26, 2011
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cellsBenjamin A Nacev, Paola Grassi, Anne Dell, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
ATRX guards against aberrant differentiation in mesenchymal progenitor cellsYan Fang, Douglas Barrows, Yakshi Dabas, et al.
Journal of Medicinal Chemistry|September 23, 2011
Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signalingWei Shi, Benjamin A Nacev, Blake T Aftab, et al.
Pageof 4